SHORELINE BIOSCIENCES

shoreline-biosciences-logo

Shoreline Biosciences is a biomedical company intended to establish immunotherapies for seriously ill patients. Its proprietary cell therapy technology platform is based on deep expertise in iPSC differentiation methods and genetic programming of the IL-15/CISH pathway for enhanced metabolic fitness and persistence of the engineered NK Cells to improve anti-cancer activity. The company was founded in 2020 and is headquartered in La Jolla, CA, USA.

#People #Financial #Event #Website #More

SHORELINE BIOSCIENCES

Industry:
Biotechnology Health Care Life Science Medical

Founded:
2020-01-01

Address:
La Jolla, California, United States

Country:
United States

Website Url:
http://www.shorelinebio.com

Total Employee:
11+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
186 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins



Current Advisors List

kleanthis-g-xanthopoulos_image

Kleanthis G. Xanthopoulos Board Member @ Shoreline Biosciences
Board_member

dan-s-kaufman_image

Dan S. Kaufman Board Member @ Shoreline Biosciences
Board_member

marios-fotiadis_image

Marios Fotiadis Board Member @ Shoreline Biosciences
Board_member

not_available_image

Christopher Fuglesang Board Member @ Shoreline Biosciences
Board_member
2021-04-01

not_available_image

Frank Yu Board Member @ Shoreline Biosciences
Board_member

steven-holtzman_image

Steven Holtzman Board Member @ Shoreline Biosciences
Board_member

Current Employees Featured

william-sandborn_image

William Sandborn
William Sandborn Co-Founder and Chief Medical Officer @ Shoreline Biosciences
Co-Founder and Chief Medical Officer
2020-07-01

kleanthis-g-xanthopoulos_image

Kleanthis G. Xanthopoulos
Kleanthis G. Xanthopoulos Co-Founder @ Shoreline Biosciences
Co-Founder

vanessa-jacoby_image

Vanessa Jacoby
Vanessa Jacoby Chief Financial Officer @ Shoreline Biosciences
Chief Financial Officer
2021-05-01

dan-s-kaufman_image

Dan S. Kaufman
Dan S. Kaufman Co-Founder and Acting Chief Scientific Officer @ Shoreline Biosciences
Co-Founder and Acting Chief Scientific Officer
2020-06-01

scott-forrest_image

Scott Forrest
Scott Forrest Chief Business Officer @ Shoreline Biosciences
Chief Business Officer
2021-10-01

robert-hollingsworth_image

Robert Hollingsworth
Robert Hollingsworth Chief Scientific Officer @ Shoreline Biosciences
Chief Scientific Officer
2022-03-01

mohammad-a-el-kalay_image

Mohammad A. El-Kalay
Mohammad A. El-Kalay Senior VP and Head of CMC @ Shoreline Biosciences
Senior VP and Head of CMC
2021-06-01

marios-fotiadis_image

Marios Fotiadis
Marios Fotiadis Co-Founder @ Shoreline Biosciences
Co-Founder

steven-holtzman_image

Steven Holtzman
Steven Holtzman Co-Founder @ Shoreline Biosciences
Co-Founder

Founder


dan-s-kaufman_image

Dan S. Kaufman

kleanthis-g-xanthopoulos_image

Kleanthis G. Xanthopoulos

marios-fotiadis_image

Marios Fotiadis

steven-holtzman_image

Steven Holtzman

william-sandborn_image

William Sandborn

Investors List

kingdon-capital_image

Kingdon Capital

Kingdon Capital investment in Series B - Shoreline Biosciences

eventide-asset-management_image

Eventide

Eventide investment in Series B - Shoreline Biosciences

wedbush-securities_image

Wedbush Securities

Wedbush Securities investment in Series B - Shoreline Biosciences

kite-pharma_image

Kite Pharma

Kite Pharma investment in Series B - Shoreline Biosciences

piper-sandler_image

Piper Sandler

Piper Sandler investment in Series B - Shoreline Biosciences

commodore-capital_image

Commodore Capital

Commodore Capital investment in Series B - Shoreline Biosciences

janus-henderson-investors_image

Janus Henderson Investors

Janus Henderson Investors investment in Series B - Shoreline Biosciences

bvf-partners_image

BVF Partners

BVF Partners investment in Series B - Shoreline Biosciences

superstring-capital_image

Superstring Capital

Superstring Capital investment in Series B - Shoreline Biosciences

cormorant-asset-management_image

Cormorant Asset Management

Cormorant Asset Management investment in Series B - Shoreline Biosciences

Official Site Inspections

http://www.shorelinebio.com Semrush global rank: 3.43 M Semrush visits lastest month: 4.5 K

  • Host name: 141.193.213.10
  • IP address: 141.193.213.10
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Shoreline Biosciences" on Search Engine